A/Prof Samantha Hocking - Healthed

Experts / A/Prof Samantha Hocking

A/Prof Samantha Hocking

Endocrinologist; Royal Prince Alfred Hospital; Clinical Academic at Charles Perkins Research Centre, University of Sydney; President, National Association of Clinical Obesity Services (NACOS)

A/Prof Samantha Hocking is an Endocrinologist at the Royal Prince Alfred Hospital and a Clinical Academic at the University of Sydney. A/Prof Hocking’s main research interest is precision medicine exploring how personalised medicine can both predict, prevent and improve the management of metabolic disease, particularly diabetes. In addition, she is working with fellow researchers at The Boden Institute and the CPC-RPA Clinic on projects in obesity, bariatric surgery, metabolic syndrome and diabetes and liver disease.

More from this expert

Diabetes and metabolism, Lifestyle

Clinical Articles

Tirzepatide vs semaglutide: A head-to-head comparison for management of obesity

The SURMOUNT-5 trial has provided definitive evidence that tirzepatide is superior to semaglutide for obesity treatment, achieving an additional 6.5% body weight reduction and nearly doubling the proportion of patients who lose 25% or more of their body weight.

Endocrinology

Podcasts

Tirzepatide compared to semaglutide for treatment of obesity – Latest evidence

A/Prof Sam Hocking provides an update on this latest study.

Diabetes and metabolism, Diet and nutrition, Drugs and devices, Endocrinology

Videos

Clinical Case: 36-year-old female with obesity

In this Quick Case Endocrinologist A/Prof Samantha Hocking presents the obesity management case of a 36-year-old female, describes treatment options, clinical outcomes, and provides some take home messages.

Diabetes and metabolism, Diet and nutrition, Drugs and devices, Endocrinology

Videos

Tirzepatide injection update & practical demonstration

In this Product Explainer, Endocrinologist A/Prof Samantha Hocking provides an update on tirzepatide injection for chronic weight management and provides a detailed demonstration of how to use the device.

Diabetes and metabolism

Videos

Pharmacotherapy for weight loss panel

A case-based approach with the latest developments on the incretin (GLP-1, GIP/GLP-1) front.

Endocrinology, Lifestyle, Pharmacology

Podcasts

Expert Panel: Pharmacotherapy for weight management

Our expert panel, facilitated by A/Prof Ralph Audehm and panelists A/Prof Samantha Hocking and Prof John Dixon, discusses pharmacotherapy for weight management, including options available, GLP-1s and setting realistic weight goals.

Diabetes and metabolism, Diet and nutrition, Drugs and devices, Endocrinology

Videos

Tirzepatide for chronic weight management

In this Product Explainer, Endocrinologist A/Prof Samantha Hocking explains the role of tirzepatide injection for chronic weight management (CWM) and how to use the device.

Diabetes and metabolism, Endocrinology

Podcasts

Weight loss maintenance – Lecture

A/Prof Samantha Hocking details why maintaining weight loss is so problematic.

Diabetes and metabolism

Podcasts

Practical guide to tirzepatide – Lecture

In this Healthed lecture, A/Prof Samantha Hocking provides an update on what this new treatment is.

Diet and nutrition, Drugs and devices, Endocrinology

Videos

The role of Liraglutide 3mg in weight management

In this Product Explainer, Endocrinologist A/Prof Samantha Hocking explains the role of Liraglutide 3mg in obesity management and patients who may benefit from it (5 mins).

The role of Liraglutide 3mg in weight management

In this Product Explainer, Endocrinologist A/Prof Samantha Hocking explains the role of Liraglutide 3mg in obesity management and patients who may benefit from it (5 mins).

By A/Prof Samantha Hocking

Videos

Diet and nutrition, Drugs and devices, Endocrinology

Practical guide to tirzepatide – Lecture

In this Healthed lecture, A/Prof Samantha Hocking provides an update on what this new treatment is.

By A/Prof Samantha Hocking

Podcasts

Diabetes and metabolism

Weight loss maintenance – Lecture

A/Prof Samantha Hocking details why maintaining weight loss is so problematic.

By A/Prof Samantha Hocking

Podcasts

Diabetes and metabolism, Endocrinology

Tirzepatide for chronic weight management

In this Product Explainer, Endocrinologist A/Prof Samantha Hocking explains the role of tirzepatide injection for chronic weight management (CWM) and how to use the device.

By A/Prof Samantha Hocking

Videos

Diabetes and metabolism, Diet and nutrition, Drugs and devices, Endocrinology

Expert Panel: Pharmacotherapy for weight management

Our expert panel, facilitated by A/Prof Ralph Audehm and panelists A/Prof Samantha Hocking and Prof John Dixon, discusses pharmacotherapy for weight management, including options available, GLP-1s and setting realistic weight goals.

By A/Prof Ralph Audehm, A/Prof Samantha Hocking, Prof John Dixon

Podcasts

Endocrinology, Lifestyle, Pharmacology

Pharmacotherapy for weight loss panel

A case-based approach with the latest developments on the incretin (GLP-1, GIP/GLP-1) front.

By A/Prof Ralph Audehm, A/Prof Samantha Hocking, Prof John Dixon

Videos

Diabetes and metabolism

Tirzepatide injection update & practical demonstration

In this Product Explainer, Endocrinologist A/Prof Samantha Hocking provides an update on tirzepatide injection for chronic weight management and provides a detailed demonstration of how to use the device.

By A/Prof Samantha Hocking

Videos

Diabetes and metabolism, Diet and nutrition, Drugs and devices, Endocrinology

Clinical Case: 36-year-old female with obesity

In this Quick Case Endocrinologist A/Prof Samantha Hocking presents the obesity management case of a 36-year-old female, describes treatment options, clinical outcomes, and provides some take home messages.

By A/Prof Samantha Hocking

Videos

Diabetes and metabolism, Diet and nutrition, Drugs and devices, Endocrinology

Tirzepatide compared to semaglutide for treatment of obesity – Latest evidence

A/Prof Sam Hocking provides an update on this latest study.

By A/Prof Samantha Hocking

Podcasts

Endocrinology

Tirzepatide vs semaglutide: A head-to-head comparison for management of obesity

The SURMOUNT-5 trial has provided definitive evidence that tirzepatide is superior to semaglutide for obesity treatment, achieving an additional 6.5% body weight reduction and nearly doubling the proportion of patients who lose 25% or more of their body weight.

By A/Prof Samantha Hocking

Clinical Articles

Diabetes and metabolism, Lifestyle

Remember me

Forgot your password?

Sign up for a free Healthed account

You are one step away from accessing the latest educational resources from Healthed.

Extra Details

Title

AHPRA number *

AHPRA Lookup

confirm-checkbox

Profession list *

Other Profession *

I have read and agree to Healthed's Terms & Conditions and Privacy Policy, and confirm that I am a healthcare professional.

Already a member? Sign in here

Back to login screen